Literature DB >> 27636599

Sexual dysfunction in medical practice.

Manohar J Shivananda1, T S Sathyanaryana Rao.   

Abstract

PURPOSE OF REVIEW: Sexual dysfunction is associated with many medical disorders. Lack of recognition of sexual dysfunction commonly occurs in medical practice. The impact of unrecognized sexual dysfunction affects quality of life, which in turn affects the recovery from medical illness. This article reviews the recent literature regarding sexual dysfunction in medical practice published in PubMed, Clinical key, Scopus, Google scholar from November 2014 to May 2016. RECENT
FINDINGS: New findings suggest that sexual dysfunction is associated with most of the disorders affecting various systems. Sexual dysfunction associated with medical disorders, apart from having effects on patients, also has impact on spouses. Sexual dysfunction may also be a predictor of future major adverse event. Prevelance of sexual dysfunction in various major illness is in the range of 20-75%. Phosphodiesterase-5 inhibitors which are first line drugs to treat erectile dysfunction cause no increase in myocardial infarction or death.
SUMMARY: Sexual functioning is impaired in neurological, endocrinal, cardiovascular, pelvic, dermatological, and other disorders. Stroke, epilepsy, traumatic brain injury, and other neurological disorders cause significant impairment in sexual functioning. Though exact correlation between androgen and sexual functioning cannot be made, androgen plays important role various phases of sexual cycle in both men and women. Diabetes has impact on all the phases of sexual cycle. Hypertension, as well as certain drugs used to treat hypertension also causes sexual dysfunction, judicious use of hypotensive drugs is recommended.

Entities:  

Mesh:

Year:  2016        PMID: 27636599     DOI: 10.1097/YCO.0000000000000281

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  4 in total

1.  The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C.

Authors:  Diego Alves Vieira; Luciana Rodrigues da Cunha; Cliviany Borges da Silva; Maria Thereza Bastos Almeida; Adriana Dias Gomes; César Lúcio Lopes de Faria; Rosângela Teixeira; Fernando Silva Neves; Gifone Aguiar Rocha; Fabrício Freire de Melo; Dulciene Maria de Magalhães Queiroz; Luciana Diniz Silva
Journal:  Qual Life Res       Date:  2019-02-07       Impact factor: 4.147

Review 2.  A systematic review of Indian studies on sexual dysfunction in patients with substance use disorders.

Authors:  Siddharth Sarkar; Nishtha Chawla; Ashlyn Tom; Prabhat Mani Pandit; Mahadev Singh Sen
Journal:  Indian J Psychiatry       Date:  2021-08-07       Impact factor: 1.759

3.  Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction.

Authors:  Mark Bieri; Elias Said; Gabrielle Antonini; Donald Dickerson; Jorge Tuma; Courtney E Bartlett; Amit N Patel; Alexander Gershman
Journal:  J Transl Med       Date:  2020-01-14       Impact factor: 5.531

4.  From Promoting Healthy Sexual Functioning to Managing Biomedical Sexual Dysfunction: Health Professional Views of Youth Sexual Health.

Authors:  Lucia F O'Sullivan; Jo Ann Majerovich; Judith Wuest
Journal:  SAGE Open Nurs       Date:  2019-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.